SCHEMBL8331839

SCHEMBL8331839

CC/C=C/CCC(CC)C(=O)O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA2 P00918 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ GRIK1 P39086 2/20 0.46
▸ GRIK2 Q13002 2/20 0.46
▸ ALDH1A1 P00352 7/20 0.44
▸ CYP19A1 P11511 4/20 0.44
▸ MAPT P10636 4/20 0.44
▸ PPARG P37231 3/20 0.44
▸ OXER1 Q8TDS5 3/20 0.44
▸ RXRA P19793 2/20 0.44
▸ FFAR1 O14842 2/20 0.44
▸ TDP1 Q9NUW8 2/20 0.43
▸ CHRM1 P11229 1/20 0.43
▸ AKR1A1 P14550 1/20 0.43
▸ CHRM3 P20309 1/20 0.43
▸ HTR2A P28223 1/20 0.43
▸ HTR2C P28335 1/20 0.43
▸ ADRA1A P35348 1/20 0.43
▸ HRH1 P35367 1/20 0.43
▸ DRD3 P35462 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7176194 1.00 CA2 (0.52) CA2MAPK1GRIK1GRIK2ALDH1A1
SCHEMBL1705894 1.00 CA2 (0.52) CA2MAPK1GRIK1GRIK2ALDH1A1
SCHEMBL14767918 0.94 ALDH1A1 (0.53) CA2MAPK1GRIK1GRIK2ALDH1A1
SCHEMBL14767917 0.94 ALDH1A1 (0.53) CA2MAPK1GRIK1GRIK2ALDH1A1
SCHEMBL2230009 0.94 ALDH1A1 (0.53) CA2MAPK1GRIK1GRIK2ALDH1A1
SCHEMBL30106406 0.94 ALDH1A1 (0.53) CA2MAPK1GRIK1GRIK2ALDH1A1
Butyric Acid SCHEMBL29786834 0.89 ALDH1A1 (0.49) CA2MAPK1ALDH1A1CYP19A1MAPT
SCHEMBL1027173 0.88 CA2 (0.59) CA2MAPK1GRIK1GRIK2ALDH1A1
SCHEMBL4683751 0.88 CA2 (0.59) CA2MAPK1GRIK1GRIK2ALDH1A1
SCHEMBL9894412 0.88 CA2 (0.57) CA2MAPK1GRIK1GRIK2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5929094-A NOVEL 3-((SUBSTITUTED) HETEROCYCLE),6-(SUBSTITUTED PHENYL)-1-OXASPIRO(4.4)NONANE DERIVATIVES; ANTAGONIZING THE EFFECT OF SUBSTANCE P BY ADMINISTERING TO BLOCK NEUROKININ-1 RECEPTORS; TREATING INFLAMMATION, MIGRAINE, EMESIS AND ASTHMA MERCK & CO., INC. (US) 1999-07-27 — — US claimed
CN-117898139-A Application of exogenous spray theanine in improving yield and quality of yellow tea 安徽农业大学 2024-04-19 — — CN disclosed
WO-2023216237-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS, AND METHODS OF USE THEREOF JS INNOMED HOLDINGS LTD. (KY) 2023-11-16 — — WO disclosed
CN-107921034-B Method of wound healing 康内克斯生命科学私人有限公司 2021-11-23 — — CN disclosed
WO-2020248972-A1 HETEROCYCLIC COMPOUNDS AS KINASE INHIBITORS, COMPOSITIONS COMPRISING THE HETEROCYCLIC COMPOUND, AND METHODS OF USE THEREOF JS INNOPHARM (SHANGHAI) LTD (CN) 2020-12-17 — — WO disclosed
US-5929094-A NOVEL 3-((SUBSTITUTED) HETEROCYCLE),6-(SUBSTITUTED PHENYL)-1-OXASPIRO(4.4)NONANE DERIVATIVES; ANTAGONIZING THE EFFECT OF SUBSTANCE P BY ADMINISTERING TO BLOCK NEUROKININ-1 RECEPTORS; TREATING INFLAMMATION, MIGRAINE, EMESIS AND ASTHMA MERCK & CO., INC. (US) 1999-07-27 — — US disclosed
US-5877191-A ANTIINFLAMMATORY AGENT; ANALGESICS; ANTIHISTAMINES; EMESIS MERCK & CO., INC. (US) 1999-03-02 — — US disclosed
Send feedback